Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens-Reference-Cited by-同舟云学术

Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens

Published:2000-12 Issue:18 Volume:37 Page:1123-1130
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Park Sung Sup,Ryu Chun Jeih,Kang Young Jun,Kashmiri S.V.S.,Hong Hyo Jeong

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference29 articles.

1. Vaccine-induced escape mutant of hepatitis B virus;Carman;Lancet,1990

2. In vivo tumor targeting of a recombinant single-chain antigen binding protein;Colcher;J. Natl. Cancer Inst.,1990

3. Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W., 1991. In Current Protocols in Immunology. National Institute of Health.

4. Design and production of novel tetravalent bispecific antibodies;Coloma;Nat. Biotech.,1997

5. Characterization of human monoclonal antibodies directed against hepatitis B surface antigen

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B;Antiviral Research;2024-09

2. A novel brick for bispecific antibody construction;Proteins: Structure, Function, and Bioinformatics;2023-03-25

3. Bispecific antibodies and its applications: a novel approach for targeting SARS-Cov-2;Journal of Basic and Clinical Physiology and Pharmacology;2023-01-06

4. Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its Implications;Infectious Disorders - Drug Targets;2019-10-04

5. In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy;Molecular Therapy - Methods & Clinical Development;2017-12